Tuberculosis in Poland, Europe, and world. Part II - Mortality, drug resistance and HIV infection;Gruźlica w Polsce, Europie i na świecie. Czȩś ć II - Umieralność, lekooporność i zakażenie HIV

Polski Merkuriusz Lekarski

Volumn 21, Issue 123, 2006, Pages 253-261

  Zielonka, Tadeusz M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Directly observed treatment short course strategy (DOTS); Epidemiology; HIV infection; Multidrug resistant TB; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

EUROPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; POLAND; PREVALENCE; REVIEW; SHORT COURSE THERAPY; TUBERCULOSIS;

AFRICA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ASIA; BCG VACCINE; COMORBIDITY; DIRECTLY OBSERVED THERAPY; EUROPE; HIV INFECTIONS; HUMANS; INCIDENCE; POLAND; PREVALENCE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; WORLD HEALTH;

EID: 33749404983     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Augustynowicz-Kopeć E., Zwolska Z., Jaworski A. i wsp.: Czȩstość wystȩpowania grużlicy lekoopomej w Polsce w 2000 r. w porównaniu z 1997 r. Pneum. Alergol. Pol., 2002, 70, 193-202.
2. Bouvet E.: Epidemiologie de la tuberculose. Prevention et prise en charge de la tuberculose en France. Rev. Mal. Respir, 2003, 20, 7S13-7S19.
3. Broekmans J.F., Migliori G., Rieder H.: European framework for tuberculosis control and elimination in countries with a law incidence. Eur. Respir. J., 2002, 19, 765-770.
4. Coninx R., Pfyffer G.E., Mathieu C.: Drug resistant tuberculosis in prison in Azerbaijan: case study. BMJ, 1998, 316, 1423-1425.
5. Corbett E.L., Steketee R.W., ter Kulle F.O. i wsp.: HIV-1/AIDS and the control of other infectious disease in Africa. Lancet, 2002, 359, 2177-2187.
6. Corbett E.L., Watt C.J., Walter N.: The growing burden of tuberculosis: global trends and interactions with the epidemic. Arch. Intern. Med., 2003, 163, 1009-1021.
7. Daley Ch.L., Hahn J., Moss A.R. i wsp.: Incidence of tuberculosis in injection drug users in San Francisco impact of energy. Am. J. Respir. Crit. Care Med., 1998, 157, 19-22.
8. Dlodlo R.A., Fujiwara P.I., Enarson D.A.: Should tuberculosis treatment and control be addressed differently in HIV-infected and HIV-uninfected individuals. Eur. Respir. J., 2005, 25, 751-757.
9. Drobniewski F., Balabanova Y., Coker R.: Clinical features, diagnosis, and management of multiple drug-resistant tuberculosis since 2002. Cur. Opin. Pulm. Med., 2004, 10, 211-217.
10. Dye Ch., Scheele S., Dolin P. i wsp.: Global burden of tuberculosis. Estimated incidence, prevalence, and mortality by country. JAMA, 1999, 282, 677-686.
11. Gilad J., Borer A., Riesenberg K. i wsp.: Epidemiology and ethnic distribution of multidrug-resistant tuberculosis in southern Israel, 1992-1997: The impact of immigration. Chest, 2000, 117, 738-743.
12. Hayward A.C., Darton T., Van-Tam J.N. i wsp.: Epidemiology and control of tuberculosis in western European cities. Int. J. Tuberc. Lung Dis., 2003, 7, 751-757.
13. Iademarco M.F., Castro K.G.: Epidemiology of tuberculosis. Sem. Respir. Infect., 2003, 18, 225-240.
14. Kawanjana J.H., Harriees A.D., Gausi F. i wsp.: TB-HIV seroprevalence in patients with tuberculosis in Malawi. Malawi Med., J. 2001, 13, 7-10.
15. Kent J.H.: The epidemiology of multidrug-resistant tuberculosis in the United States. Med. Clin. North Am., 1993, 77, 1391-1409.
16. Kubin M., Prikazsky V., Havelkova M.i wsp.: Present state of tuberculosis in the Czech Republic and in central European and Baltic countries. Central Eur. J. Public Health, 1999, 7, 109-115.
17. Kruuner A., Sillast H., Danilovitch M.: Drug resistant tuberculosis in Estonia. Int. J. Tuberc. Lung Dis., 1998, 2, 130-133.
18. Li J.H., Driver C.R., Munsiff S.S. i wsp.: Differential decline in tuberculosis incidence among US-born and non-US-born persons in New York city. Int. J. Tuberc. Lung Dis., 2003, 7, 451-457
19. Loddenkemper R.: European lung white book. ERSJ Ltd 2003.
20. Long R., Njoo H., Hershfield E.: Tuberculosis: epidemiology of the disease in Canada. Can. Med. A. J., 1999, 160, 1185-1190.
21. Migliori G.B.: Tuberculosis management in Europe. Eur. Respir. J., 1999, 14, 978-984.
22. Murray J.F.: La tuberculosis dans le monde: situation et perspective en l'an 2001. Rev. Mal. Respir., 2001, 18, 479-483.
23. Perez-Perdomo R., Perez-Cardona C.M., Suarez-Perez E.: The epidemiology of tuberculosis in patients with AIDS in Puerto Rico: morbidity and survival, 1981-1998. Int. J. Tuberc. Lung Dis., 2000, 4, 713-718.
24. Podlesin R., Cholewińska G., Horban A. i wsp.: Opportunistic infection and other AIDS-defming illnesses in Poland in 2002. HIV AIDS Rev., 2003, 2, 109-114.
25. Robert J., Trystram D., Truffot-Pernot C. i wsp.: Twenty-five years of tuberculosis in a French university hospital: a laboratory perspective. Int. J. Tuberc. Lung Dis., 2000, 4, 504-512.
26. Rowińska-Zakrzewska E., Szopiński J., Remiszewski P. i wsp.: Tuberculosis in the autopsy material: analysis of 1500 autopsies performed between 1972 and 1991 in the Institute of Tuberculosis and Chest Diseases, Warsaw, Poland. Tubercle Lung Dis., 1995, 76, 349-354.
27. Rusch-Gerdes S.: Epidemiology of resistant tuberculosis in Europe. Infection, 1999, 27, suppl. 2, S17-S18.
28. Smith A., O'Flanagan D., Igoe D.: Tuberculosis in the Republic of Ireland at the end of the 1990s. Irish Med. J., 2002, 95, 138-139.
29. Stout J.E. Ratard R. Southwick K.L. i wsp.: Epidemiology of human immunodeficiency virus testing among patients with tuberculosis in North Carolina. South Med. J., 2002, 95, 231-38. Surveillance, planning, financing. WHO Report 2004. Geneva, Switzerland, ISBN 92 4 1.
30. Szczuka I.: Gruźlica i choroby układu oddechowego w Polsce w 2003 roku. Warszawa. 2004.
31. Wang P.: Epidemiology and control of tuberculosis in Taipei. J. Infect., 2002, 45, 82-87.
32. WHO. Global Tuberculosis Control. 56264 1.
33. Zhang L.X., Tu D.H., Enarson D.A.: The impact of directly-observed treatment on the epidemiology of tuberculosis in Beijing. Int. J. Tuberc. Lung Dis., 2000, 4, 904-910.
34. WHO. What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. Geneva, Switzerland: WHO. 1999.